Akers Biosciences (NASDAQ: AKER) announces an update on the progress of its 19.9%-owned Chinese joint venture company, Hainan Savy Akers ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE